01.12.2016
- Talks between Valeant and Takeda about a takeover of Valeant’s Salix subsidiary for $10 billion have broken down amid disagreements over price, among other things, according to the...
03.11.2016
- Valeant Pharmaceuticals is in advanced discussions with Japan’s Takeda to sell its Salix subsidiary for $10 billion, according to the US business newspaper Wall Street Journal. The...
25.04.2016
- In its search for a new CEO to replace William J. Pearson, who has resigned amid several controversies, Canada-domiciled embattled drugmaker Valeant is said to be finalizing a...
02.01.2013
- U.S. regulators approved 39 new drugs in 2012, the most in 16 years, suggesting that pharmaceutical makers are poised for growth after losing billions of dollars in recent years to...
